<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 7 Issue 3</issue_number>
<issue_period>2016 (July - September)</issue_period>
<title>ATRANORIN SECONDARY METABOLITE FROM LICHEN Usnea sp. AND ITS ANTIBACTERIAL ACTIVITY</title>
<abstract>Isolation and identification of secondary metabolites from lichen Usnea sp. fraction of n-hexane and its activity against bacteria have been carried out. The isolation was done by maceration extraction with methanol, then performed a partition with n-hexane solvent. Fractions of n-hexane was then separated by gravity column chromatography (GCC) and thin layer chromatography (TLC) techniques using a gradient eluent mixture of nhexane : ethyl acetate. The results of data analysis-1D NMR spectroscopy (1H and 13C-NMR), 2D NMR (HMQC, HMBC and 1H-1H COSY) were compared with similar data from the literature. The isolated compound was identified as atranorin. The antibacterial activities test were applied on the fraction of n-hexane and isolated compound. Test results of n-hexane fraction activity against Escherichia coli (ATCC 35218), Staphylococcus aureus (ATCC 25923) and Salmonella typhi (YCTC) with a diameter of inhibition zone on the concentration of 500 mg/mL were 9.33, 10.6 and 10.6 mm, respectively. While, test of isolated compound activity against the same three types of bacteria at concentrations of 500 mg/mL were 3.0, 4.0 and 5.3 mm, respectively. </abstract>
<authors>MAULIDIYAH, SITTI HADIJAH SABARWATI, EKA SAFUTRA, MUHAMMAD NURDIN</authors>
<keywords>Isolation, identification, lichen, Usnea sp., antibacterial, atranorin</keywords>
<pages>159-169</pages>
</article>
</Journal>
